Esophagitis in Non-Small Cell Lung Carcinoma Treatment Caused by Pembrolizumab

被引：5
|
作者：
Yoshida, Sonoe [1 ]
Miyamoto, Shuichi [1 ,2 ]
Naruse, Hirohito [1 ]
Ito, Jun [1 ]
Kinosita, Kenji [1 ]
Kudo, Taiki [1 ]
Hatanaka, Kazuteru [1 ]
Yamamoto, Yoshiya [1 ]
Sakamoto, Naoya [2 ]
机构：
[1] Hakodate Municipal Hosp, Dept Gastroenterol & Hepatol, Hakodate, Hokkaido, Japan
[2] Hokkaido Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Sapporo, Hokkaido, Japan
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2020年 / 115卷 / 01期
关键词：
D O I：
10.14309/ajg.0000000000000324
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：13 / 13
页数：1
相关论文
共 50 条
  • [21] Low-dose pembrolizumab in the treatment of advanced non-small cell lung cancer
    Low, Jia Li
    Huang, Yiqing
    Sooi, Kenneth
    Ang, Yvonne
    Chan, Zhi Yao
    Spencer, Katie
    Jeyasekharan, Anand Devaprasath
    Sundar, Raghav
    Goh, Boon Cher
    Soo, Ross
    Yong, Wei Peng
    INTERNATIONAL JOURNAL OF CANCER, 2021, 149 (01) : 169 - 176
  • [22] Pembrolizumab in the treatment of metastatic non-small cell lung cancer: a review of current evidence
    Rihawi, Karim
    Gelsomino, Francesco
    Sperandi, Francesca
    Melotti, Barbara
    Fiorentino, Michelangelo
    Casolari, Laura
    Ardizzoni, Andrea
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2017, 11 (09) : 353 - 373
  • [23] The evolving use of pembrolizumab in combination treatment approaches for non-small cell lung cancer
    Alexander, Mariam
    Ko, Brian
    Lambert, Remy
    Gadgeel, Shirish
    Halmos, Balazs
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2020, 14 (02) : 137 - 147
  • [24] Right ventricular outflow obstruction caused by non-small cell lung carcinoma
    Zakynthinos, EG
    Kontogianni, DD
    Mpalafouta, ME
    Vassilakopoulos, T
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2000, 75 (2-3) : 313 - 314
  • [25] HYPOKALEMIA CAUSED BY PARANEOPLASTIC SYNDROME IN THE SETTING OF NON-SMALL CELL LUNG CARCINOMA
    Dunmyre, Brandon
    Prosek, Jason
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2020, 75 (04) : 564 - 565
  • [26] Advances in the Treatment of Non-small Cell Lung Cancer: Focus on Nivolumab, Pembrolizumab, and Atezolizumab
    Leventakos, Konstantinos
    Mansfield, Aaron S.
    BIODRUGS, 2016, 30 (05) : 397 - 405
  • [27] COST-EFFECTIVENESS OF PEMBROLIZUMAB FOR THE FIRST-LINE TREATMENT OF METASTATIC NON-SMALL CELL LUNG CARCINOMA IN PORTUGAL
    Pinheiro, B. A.
    Alarcao, J.
    Silva Miguel, L.
    Huang, M.
    Chandwani, S.
    Vargas Lopes, F.
    Borges, M.
    VALUE IN HEALTH, 2017, 20 (09) : A432 - A432
  • [28] Undifferentiated carcinoma of the transverse colon with rhabdoid features that developed during treatment of non-small cell lung carcinoma with pembrolizumab: a case report
    Yuya Ashitomi
    Mitsuhiro Yano
    Michihisa Kono
    Takefumi Suzuki
    Ichiro Kawamura
    Shinji Okazaki
    Yukinori Kamio
    Osamu Hachiya
    Yuka Urano
    Fuyuhiko Motoi
    Surgical Case Reports, 6
  • [29] Undifferentiated carcinoma of the transverse colon with rhabdoid features that developed during treatment of non-small cell lung carcinoma with pembrolizumab: a case report
    Ashitomi, Yuya
    Yano, Mitsuhiro
    Kono, Michihisa
    Suzuki, Takefumi
    Kawamura, Ichiro
    Okazaki, Shinji
    Kamio, Yukinori
    Hachiya, Osamu
    Urano, Yuka
    Motoi, Fuyuhiko
    SURGICAL CASE REPORTS, 2020, 6 (01)
  • [30] Hypoxia as a Cause of Treatment Failure in Non-Small Cell Carcinoma of the Lung
    Brustugun, Odd Terje
    SEMINARS IN RADIATION ONCOLOGY, 2015, 25 (02) : 87 - 92
12345